These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 6455822)

  • 1. Nonspecific inhibition of alloantigen-induced proliferation by bone marrow natural regulatory cells.
    Dorshkind K; Rosse C
    Transplant Proc; 1981 Mar; 13(1 Pt 2):1182-6. PubMed ID: 6455822
    [No Abstract]   [Full Text] [Related]  

  • 2. Specific immune suppression in adult mice across K-I-D fully allogeneic histoincompatibility barriers induced by lymphocyte-free bone marrow cells.
    Müller-Ruchholtz W; Blank M; Wottge HU; Müller-Hermelink HK
    Transplant Proc; 1981 Mar; 13(1 Pt 1):603-7. PubMed ID: 7022898
    [No Abstract]   [Full Text] [Related]  

  • 3. Functional evaluation of mouse bone marrow T lymphocytes.
    Brochu S; Perreault C
    Transplantation; 1993 Nov; 56(5):1263-5. PubMed ID: 8249135
    [No Abstract]   [Full Text] [Related]  

  • 4. Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation.
    Truitt RL; Johnson BD; Hanke C; Talib S; Hearst JE
    J Immunol; 1999 Nov; 163(9):5145-56. PubMed ID: 10528221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Regulatory role of the bone marrow in the immune response--stimulation and suppression].
    Petrov RV; Khaitov RM; Ataullakhanov RI; Sidorovich IG
    Dokl Akad Nauk SSSR; 1977; 237(4):990-3. PubMed ID: 145361
    [No Abstract]   [Full Text] [Related]  

  • 6. Detection of H-Y-reactive T lymphocytes in primary mixed lymphocyte reaction in DA rats.
    Sugiura W; Miyamoto M; Kimura H; Imada M; Tsujimura K; Honda M; Yamashita A
    Transplant Proc; 1995 Apr; 27(2):1593-5. PubMed ID: 7725418
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term survival of murine allogeneic bone marrow chimeras: effect of anti-lymphocyte serum and bone marrow dose.
    Norin AJ; Emeson EE; Veith FJ
    J Immunol; 1981 Feb; 126(2):428-32. PubMed ID: 7451985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM; Gorechlad J; Larsen CP; Waller EK
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alloantigen-activated CML suppression independent of cytotoxic activity.
    Orosz CG; Bach FH
    J Immunol; 1979 Sep; 123(3):1419-21. PubMed ID: 157373
    [No Abstract]   [Full Text] [Related]  

  • 10. Ganoderma lucidum polysaccharides enhance the function of immunological effector cells in immunosuppressed mice.
    Zhu XL; Chen AF; Lin ZB
    J Ethnopharmacol; 2007 May; 111(2):219-26. PubMed ID: 17182202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of cells presenting the erythroblast antigen on the natural suppressor activity of nonadhesive bone marrow cells].
    Kusmartsev SA; Agranovich IM; Bel'skiĭ IuP; Goncharskaia MA
    Biull Eksp Biol Med; 1993 Jun; 115(6):652-4. PubMed ID: 8374150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic bone marrow inhibits T-cell activation and clonal expansion in vitro.
    George JF; Lu A; Thomas JM; Kirklin JK; Pinderski LJ
    Transplantation; 2003 Jul; 76(1):237-43. PubMed ID: 12865816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphoblast-mediated nonspecific suppression of alloantigen-induced cytotoxicity.
    Ferguson RM; Simmons RL
    Transplant Proc; 1979 Mar; 11(1):910-3. PubMed ID: 452108
    [No Abstract]   [Full Text] [Related]  

  • 14. Bone marrow cells as cytostatic effectors responsible for suppressing leukemia growth in vitro.
    Seledtsov VI; Avdeev IV; Seledtsova GV; Samarin DM; Prokopenko IV; Kozlov VA
    Biomed Pharmacother; 1995; 49(6):293-9. PubMed ID: 7579011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor growth inhibitory and natural suppressor activities of murine bone marrow cells: a comparative study.
    Seledtsov VI; Taraban VY; Seledtsova GV; Samarin DM; Avdeev IV; Senyukov VV; Kozlov VA
    Cell Immunol; 1997 Nov; 182(1):12-9. PubMed ID: 9427805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of autoimmune diabetes by interleukin 3-dependent bone marrow-derived cells in NOD mice.
    Ito A; Aoyanagi N; Maki T
    J Autoimmun; 1997 Aug; 10(4):331-8. PubMed ID: 9237796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway.
    Augello A; Tasso R; Negrini SM; Amateis A; Indiveri F; Cancedda R; Pennesi G
    Eur J Immunol; 2005 May; 35(5):1482-90. PubMed ID: 15827960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance induction using autologous bone marrow modified with an allogeneic class I MHC gene.
    Sachs DH; Bodine DM; Moulton AD; Pearson DA; Nienhuis AW; Sykes M
    Transplant Proc; 1993 Feb; 25(1 Pt 1):348-9. PubMed ID: 8438329
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunologic phenotype and function in human bone marrow, blood stem cells and umbilical cord blood.
    Mills KC; Gross TG; Varney ML; Heimann DG; Reed EC; Kessinger A; Talmadge JE
    Bone Marrow Transplant; 1996 Jul; 18(1):53-61. PubMed ID: 8831996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H-2 restriction of the T cell response to chemically induced tumors: evidence from F1 replaced by parent chimeras.
    Lannin DR; Yu S; McKhann CF
    J Immunol; 1982 Jan; 128(1):263-8. PubMed ID: 6459368
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.